<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<title>Patient Summary Dashboard - SULLIVAN, KAREN</title>
<style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            padding: 20px;
            color: #333;
        }
        
        .container {
            max-width: 1400px;
            margin: 0 auto;
            background: white;
            border-radius: 10px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.2);
            overflow: hidden;
        }
        
        .header {
            background: linear-gradient(135deg, #d53f8c 0%, #b83280 100%);
            color: white;
            padding: 30px;
            text-align: center;
        }
        
        .header h1 {
            font-size: 32px;
            margin-bottom: 10px;
        }
        
        .header p {
            font-size: 14px;
            opacity: 0.9;
        }
        
        .patient-info {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 20px;
            padding: 30px;
            background: #fef5f7;
            border-bottom: 3px solid #fbb6ce;
        }
        
        .info-card {
            background: white;
            padding: 20px;
            border-radius: 8px;
            box-shadow: 0 2px 8px rgba(0,0,0,0.1);
            border-left: 4px solid #ed64a6;
        }
        
        .info-card h3 {
            color: #2d3748;
            font-size: 14px;
            text-transform: uppercase;
            letter-spacing: 1px;
            margin-bottom: 10px;
        }
        
        .info-card p {
            font-size: 18px;
            font-weight: 600;
            color: #4a5568;
        }
        
        .content {
            padding: 30px;
        }
        
        .section {
            margin-bottom: 40px;
        }
        
        .section h2 {
            color: #2d3748;
            font-size: 24px;
            margin-bottom: 20px;
            padding-bottom: 10px;
            border-bottom: 2px solid #e2e8f0;
        }
        
        .diagnosis-list {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 15px;
        }
        
        .diagnosis-item {
            background: #fff5f7;
            border-left: 4px solid #ed64a6;
            padding: 15px;
            border-radius: 5px;
        }
        
        .diagnosis-item.chronic {
            background: #fffaf0;
            border-left-color: #ed8936;
        }
        
        .diagnosis-item h4 {
            color: #2d3748;
            margin-bottom: 8px;
        }
        
        .diagnosis-item p {
            font-size: 14px;
            color: #718096;
            margin-bottom: 4px;
        }
        
        .alert {
            background: #fef5e7;
            border-left: 4px solid #f39c12;
            padding: 15px;
            margin: 20px 0;
            border-radius: 5px;
        }
        
        .alert h4 {
            color: #d68910;
            margin-bottom: 8px;
        }
        
        .alert p {
            color: #7c5d10;
            font-size: 14px;
        }
        
        .timeline {
            position: relative;
            padding-left: 40px;
        }
        
        .timeline::before {
            content: '';
            position: absolute;
            left: 10px;
            top: 0;
            bottom: 0;
            width: 2px;
            background: #cbd5e0;
        }
        
        .timeline-item {
            position: relative;
            margin-bottom: 30px;
            padding-left: 20px;
        }
        
        .timeline-item::before {
            content: '';
            position: absolute;
            left: -34px;
            top: 5px;
            width: 12px;
            height: 12px;
            border-radius: 50%;
            background: #ed64a6;
            border: 3px solid white;
            box-shadow: 0 0 0 2px #ed64a6;
        }
        
        .timeline-item.critical::before {
            background: #f56565;
            box-shadow: 0 0 0 2px #f56565;
        }
        
        .timeline-date {
            font-weight: 600;
            color: #ed64a6;
            margin-bottom: 5px;
        }
        
        .timeline-content {
            background: #f7fafc;
            padding: 15px;
            border-radius: 5px;
            border: 1px solid #e2e8f0;
        }
        
        .timeline-content h4 {
            color: #2d3748;
            margin-bottom: 8px;
        }
        
        .timeline-content p {
            font-size: 14px;
            color: #4a5568;
            line-height: 1.6;
            margin-bottom: 6px;
        }
        
        .lab-table {
            width: 100%;
            border-collapse: collapse;
            margin-top: 15px;
        }
        
        .lab-table th {
            background: #b83280;
            color: white;
            padding: 12px;
            text-align: left;
            font-weight: 600;
        }
        
        .lab-table td {
            padding: 10px 12px;
            border-bottom: 1px solid #e2e8f0;
        }
        
        .lab-table tr:hover {
            background: #fef5f7;
        }
        
        .lab-table td strong {
            font-weight: 700;
            color: #2d3748;
        }
        
        .status-badge {
            display: inline-block;
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 12px;
            font-weight: 600;
        }
        
        .status-normal {
            background: #c6f6d5;
            color: #22543d;
        }
        
        .status-abnormal {
            background: #fed7d7;
            color: #742a2a;
        }
        
        .status-elevated {
            background: #feebc8;
            color: #7c2d12;
        }
        
        .followup-list {
            background: #f7fafc;
            padding: 20px;
            border-radius: 8px;
            border: 1px solid #e2e8f0;
        }
        
        .followup-list ul {
            list-style: none;
            padding-left: 0;
        }
        
        .followup-list li {
            padding: 8px 0;
            padding-left: 25px;
            position: relative;
            color: #4a5568;
        }
        
        .followup-list li::before {
            content: '‚úì';
            position: absolute;
            left: 0;
            color: #48bb78;
            font-weight: bold;
        }
        
        .appointment-card {
            background: white;
            border: 1px solid #e2e8f0;
            border-left: 4px solid #ed64a6;
            padding: 15px;
            margin-bottom: 10px;
            border-radius: 5px;
        }
        
        .appointment-card h4 {
            color: #2d3748;
            margin-bottom: 5px;
        }
        
        .appointment-card p {
            font-size: 14px;
            color: #718096;
        }
        
        .footer {
            background: #2d3748;
            color: white;
            text-align: center;
            padding: 20px;
            font-size: 12px;
        }
        
        @media print {
            body {
                background: white;
                padding: 0;
            }
            .container {
                box-shadow: none;
            }
        }
    </style>
</head>
<body>
<div class="container">
<div class="header">
<h1>PATIENT MEDICAL SUMMARY</h1>
<p>Metropolitan Cancer Center | Breast Oncology Department</p>
<p>Generated: November 15, 2024 | Report ID: EHR-2024-11-789321</p>
</div>
<div class="patient-info">
<div class="info-card">
<h3>Patient Name</h3>
<p>SULLIVAN, KAREN</p>
</div>
<div class="info-card">
<h3>Medical Record Number</h3>
<p>MRN-2024-789321</p>
</div>
<div class="info-card">
<h3>Date of Birth</h3>
<p>03/20/1969 (55 years)</p>
</div>
<div class="info-card">
<h3>Sex</h3>
<p>Female</p>
</div>
<div class="info-card">
<h3>Primary Physician</h3>
<p>Dr. Jennifer Martinez, MD</p>
</div>
<div class="info-card">
<h3>Last Visit</h3>
<p>11/15/2024</p>
</div>
</div>
<div class="content">
<!-- Active Diagnoses -->
<div class="section">
<h2>üî¥ Active &amp; Chronic Diagnoses</h2>
<div class="diagnosis-list">
<div class="diagnosis-item">
<nav><a href="#invasive-ductal-carcinoma">Invasive Ductal Carcinoma (Active)</a></nav>
<p><strong>Location:</strong> Left breast, upper outer quadrant</p>
<p><strong>Stage:</strong> T2N1M0 (Stage IIA)</p>
<p><strong>Tumor Size:</strong> 2.8 cm (MRI)</p>
<p><strong>Lymph Nodes:</strong> 1 positive micrometastasis / 3 examined</p>
<p><strong>Diagnosed:</strong> January 2024</p>
<p><strong>Status:</strong> Treatment planning - Lumpectomy + radiation + endocrine therapy</p>
</div>
<div class="diagnosis-item">
<nav><a href="#hormone-receptor-status">Hormone Receptor Status</a></nav>
<p><strong>ER:</strong> Positive</p>
<p><strong>PR:</strong> Positive</p>
<p><strong>HER2:</strong> Negative (IHC 1+, FISH not amplified)</p>
<p><strong>Subtype:</strong> Luminal A (ER+/PR+/HER2-)</p>
<p><strong>Clinical Significance:</strong> Excellent response to endocrine therapy expected</p>
</div>
<div class="diagnosis-item chronic">
<nav><a href="#postmenopausal-status">Postmenopausal Status</a></nav>
<p><strong>Menopause Age:</strong> 51 years</p>
<p><strong>Years Postmenopausal:</strong> 4 years</p>
<p><strong>Significance:</strong> Eligible for aromatase inhibitor therapy</p>
</div>
<div class="diagnosis-item chronic">
<h4>Osteopenia (Mild)</h4>
<p><strong>Diagnosed:</strong> 2022</p>
<p><strong>Status:</strong> Monitored with DEXA scans, vitamin D supplementation</p>
<p><strong>Note:</strong> Important consideration with aromatase inhibitor use</p>
</div>
</div>
<div class="alert">
<h4>‚ö†Ô∏è Oncotype DX Testing Pending</h4>
<p>Oncotype DX genomic assay ordered to assess recurrence risk and chemotherapy benefit. Results expected within 2 weeks. Recurrence Score of 18 received (Low Risk) - chemotherapy not indicated.</p>
</div>
</div>
<!-- Treatment Timeline -->
<div class="section">
<h2>üìÖ Treatment Timeline</h2>
<div class="timeline">
<div class="timeline-item">
<div class="timeline-date">January 15, 2021</div>
<div class="timeline-content">
<h4>Routine Screening Mammogram</h4>
<p><strong>Details:</strong> Annual screening mammogram. No suspicious findings. BI-RADS 1 (negative).</p>
<p><strong>Outcome:</strong> Continue annual screening</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">September 10, 2022</div>
<div class="timeline-content">
<h4>Screening Mammogram</h4>
<p><strong>Details:</strong> Routine annual screening. Subtle architectural distortion noted in left breast upper outer quadrant. BI-RADS 3 (probably benign).</p>
<p><strong>Recommendation:</strong> Short-interval follow-up in 6 months</p>
<p><strong>Outcome:</strong> Patient scheduled for follow-up</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">August 20, 2023</div>
<div class="timeline-content">
<h4>Follow-up Mammogram and Ultrasound</h4>
<p><strong>Mammogram:</strong> Architectural distortion increased in size. BI-RADS 4 (suspicious).</p>
<p><strong>Ultrasound:</strong> 2.3 cm irregular hypoechoic mass with posterior shadowing</p>
<p><strong>Outcome:</strong> Core needle biopsy recommended</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">September 5, 2023</div>
<div class="timeline-content">
<h4>Self-Detected Breast Lump</h4>
<p><strong>Details:</strong> Patient detected palpable lump in left breast while showering. Presented to primary care physician.</p>
<p><strong>Physical Exam:</strong> 2-3 cm firm, irregular mass in left upper outer quadrant. No skin changes, no nipple discharge.</p>
<p><strong>Outcome:</strong> Urgent referral to breast surgery</p>
</div>
</div>
<div class="timeline-item critical" id="postmenopausal-status">
<div class="timeline-date">September 15, 2023</div>
<div class="timeline-content">
<h4>Core Needle Biopsy</h4>
<p><strong>Procedure:</strong> Ultrasound-guided core needle biopsy of left breast mass</p>
<p><strong>Pathology:</strong> Invasive ductal carcinoma, Grade 2</p>
<p><strong>Receptor Status:</strong> ER+ (95%), PR+ (80%), HER2- (IHC 1+)</p>
<p><strong>Outcome:</strong> Diagnosis confirmed - Breast cancer</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">October 5, 2023</div>
<div class="timeline-content">
<h4>Breast MRI</h4>
<p><strong>Findings:</strong> 2.8 cm enhancing mass in left upper outer quadrant. No additional suspicious lesions. No chest wall invasion.</p>
<p><strong>Assessment:</strong> Unifocal disease, suitable for breast-conserving surgery</p>
<p><strong>Outcome:</strong> Lumpectomy planned</p>
</div>
</div>
<div class="timeline-item critical">
<div class="timeline-date">November 10, 2023</div>
<div class="timeline-content">
<h4>Lumpectomy with Sentinel Lymph Node Biopsy</h4>
<p><strong>Procedure:</strong> Left breast lumpectomy with sentinel lymph node evaluation</p>
<p><strong>Pathology:</strong> 2.8 cm invasive ductal carcinoma, Grade 2, margins negative (5 mm)</p>
<p><strong>Lymph Nodes:</strong> 1/3 sentinel nodes positive for micrometastasis (0.8 mm)</p>
<p><strong>Final Stage:</strong> pT2N1mi(sn)M0 - Stage IIA</p>
<p><strong>Outcome:</strong> Successful surgery, no complications</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">December 1, 2023</div>
<div class="timeline-content">
<h4>Oncotype DX Results</h4>
<p><strong>Recurrence Score:</strong> 18 (Low Risk)</p>
<p><strong>Interpretation:</strong> Low risk of distant recurrence. Minimal benefit from chemotherapy.</p>
<p><strong>Recommendation:</strong> Endocrine therapy alone (no chemotherapy)</p>
<p><strong>Outcome:</strong> Patient relieved, agrees with recommendation</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">January 15, 2024</div>
<div class="timeline-content">
<h4>Radiation Oncology Consultation</h4>
<p><strong>Plan:</strong> Whole-breast irradiation with hypofractionated regimen</p>
<p><strong>Dose:</strong> 42.56 Gy in 16 fractions (2.66 Gy per fraction)</p>
<p><strong>Technique:</strong> Deep inspiration breath hold (DIBH) to minimize cardiac dose</p>
<p><strong>Duration:</strong> 3.5 weeks</p>
<p><strong>Outcome:</strong> Radiation therapy scheduled to start February 2024</p>
</div>
</div>
<div class="timeline-item critical">
<div class="timeline-date">February 5, 2024</div>
<div class="timeline-content">
<h4>Radiation Therapy Started</h4>
<p><strong>Details:</strong> Whole-breast irradiation initiated. DIBH technique. Daily treatments Monday-Friday.</p>
<p><strong>Status:</strong> Tolerating well, mild skin erythema</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">March 1, 2024</div>
<div class="timeline-content">
<h4>Radiation Therapy Completed</h4>
<p><strong>Details:</strong> All 16 fractions delivered. Total dose: 42.56 Gy.</p>
<p><strong>Acute Toxicity:</strong> Grade 1 skin erythema, mild breast tenderness</p>
<p><strong>Outcome:</strong> Excellent treatment completion</p>
</div>
</div>
<div class="timeline-item critical">
<div class="timeline-date">March 15, 2024</div>
<div class="timeline-content">
<h4>Endocrine Therapy Initiated</h4>
<p><strong>Medication:</strong> Letrozole (Femara) 2.5 mg daily</p>
<p><strong>Duration:</strong> 5 years minimum</p>
<p><strong>Monitoring:</strong> Bone density scans, lipid panels, liver function tests</p>
<p><strong>Outcome:</strong> Patient educated on side effects, importance of adherence</p>
</div>
</div>
<div class="timeline-item">
<div class="timeline-date">November 15, 2024</div>
<div class="timeline-content">
<h4>Current Visit - 8-Month Follow-up</h4>
<p><strong>Details:</strong> Patient doing well on Letrozole. Mild joint stiffness (manageable). No signs of recurrence.</p>
<p><strong>Physical Exam:</strong> Surgical site well-healed. No masses, no lymphadenopathy.</p>
<p><strong>Labs:</strong> CA 15-3: 28 U/mL (normal). CBC, CMP normal.</p>
<p><strong>Outcome:</strong> Continue current plan, follow-up in 3 months</p>
</div>
</div>
</div>
</div>
<!-- Recent Labs -->
<div class="section">
<h2>üî¨ Most Recent Laboratory Results (11/15/2024)</h2>
<table class="lab-table">
<thead>
<tr>
<th>Test</th>
<th>Result</th>
<th>Units</th>
<th>Reference Range</th>
<th>Status</th>
</tr>
</thead>
<tbody>
<tr>
<td>CA 15-3 (Tumor Marker)</td>
<td><strong>28</strong></td>
<td>U/mL</td>
<td>0-30</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
<tr>
<td>Hemoglobin</td>
<td><strong>12.4</strong></td>
<td>g/dL</td>
<td>12.0-16.0</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
<tr>
<td>WBC</td>
<td><strong>6.2</strong></td>
<td>K/uL</td>
<td>4.5-11.0</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
<tr>
<td>Platelet</td>
<td><strong>235</strong></td>
<td>K/uL</td>
<td>150-400</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
<tr>
<td>Creatinine</td>
<td><strong>0.8</strong></td>
<td>mg/dL</td>
<td>0.6-1.2</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
<tr>
<td>ALT</td>
<td><strong>24</strong></td>
<td>U/L</td>
<td>7-56</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
<tr>
<td>Vitamin D</td>
<td><strong>32</strong></td>
<td>ng/mL</td>
<td>30-100</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
<tr>
<td>Total Cholesterol</td>
<td><strong>198</strong></td>
<td>mg/dL</td>
<td>&lt;200</td>
<td><span class="status-badge status-normal">Normal</span></td>
</tr>
</tbody>
</table>
</div>
<!-- Current Medications -->
<div class="section">
<h2>üíä Current Medications</h2>
<table class="lab-table">
<thead>
<tr>
<th>Medication</th>
<th>Dose</th>
<th>Frequency</th>
<th>Indication</th>
<th>Status</th>
</tr>
</thead>
<tbody>
<tr>
<td>Letrozole (Femara)</td>
<td>2.5 mg PO</td>
<td>Daily</td>
<td>Adjuvant endocrine therapy for breast cancer</td>
<td><span class="status-badge status-normal">Active</span></td>
</tr>
<tr>
<td>Vitamin D3</td>
<td>2000 IU PO</td>
<td>Daily</td>
<td>Bone health (aromatase inhibitor use)</td>
<td><span class="status-badge status-normal">Active</span></td>
</tr>
<tr>
<td>Calcium carbonate</td>
<td>600 mg PO</td>
<td>Twice daily</td>
<td>Bone health (aromatase inhibitor use)</td>
<td><span class="status-badge status-normal">Active</span></td>
</tr>
<tr>
<td>Omega-3 fatty acids</td>
<td>1000 mg PO</td>
<td>Daily</td>
<td>Cardiovascular health</td>
<td><span class="status-badge status-normal">Active</span></td>
</tr>
<tr>
<td>Multivitamin</td>
<td>1 tablet PO</td>
<td>Daily</td>
<td>Nutritional support</td>
<td><span class="status-badge status-normal">Active</span></td>
</tr>
<tr>
<td>Ibuprofen</td>
<td>400 mg PO</td>
<td>As needed</td>
<td>Joint pain (AI-related arthralgia)</td>
<td><span class="status-badge status-normal">PRN</span></td>
</tr>
</tbody>
</table>
</div>
<!-- Follow-up Plan -->
<div class="section">
<h2>üìã Follow-up Plan</h2>
<h3 style="color: #2d3748; margin-top: 20px; margin-bottom: 15px;">Breast Cancer Surveillance</h3>
<div class="followup-list">
<ul>
<li>Clinical breast exam every 3-6 months for first 3 years</li>
<li>Then every 6-12 months for years 4-5</li>
<li>Then annually after 5 years</li>
<li>Annual mammogram (bilateral)</li>
<li>CA 15-3 tumor marker every 6 months (optional)</li>
<li>DEXA scan every 2 years (monitor bone density on AI)</li>
<li>Lipid panel annually</li>
<li>Liver function tests every 6 months</li>
<li>Genetic counseling referral (family history of breast cancer)</li>
</ul>
</div>
<h3 style="color: #2d3748; margin-top: 25px; margin-bottom: 15px;">Next Scheduled Appointments</h3>
<div class="appointment-card">
<h4>Medical Oncology - February 15, 2025</h4>
<p><strong>Provider:</strong> Dr. Jennifer Martinez, MD</p>
<p><strong>Purpose:</strong> 3-month follow-up, assess Letrozole tolerance, physical exam</p>
</div>
<div class="appointment-card">
<h4>Breast Surgery - March 2025</h4>
<p><strong>Provider:</strong> Dr. Amanda Chen, MD</p>
<p><strong>Purpose:</strong> Annual surgical follow-up, clinical breast exam</p>
</div>
<div class="appointment-card">
<h4>Radiology - April 2025</h4>
<p><strong>Provider:</strong> Breast Imaging Center</p>
<p><strong>Purpose:</strong> Annual screening mammogram (bilateral)</p>
</div>
<div class="appointment-card">
<h4>Genetic Counseling - January 2025</h4>
<p><strong>Provider:</strong> Ms. Rachel Thompson, MS, CGC</p>
<p><strong>Purpose:</strong> Discuss family history, BRCA1/2 testing options</p>
</div>
<div class="appointment-card">
<h4>Primary Care - May 2025</h4>
<p><strong>Provider:</strong> Dr. Lisa Johnson, MD</p>
<p><strong>Purpose:</strong> Annual physical, general health maintenance</p>
</div>
</div>
</div>
<div class="footer">
<p>Metropolitan Cancer Center | Department of Breast Oncology</p>
<p>This document contains protected health information (PHI) and is confidential.</p>
<p>Generated: 11/15/2024 17:45 | Report ID: EHR-2024-11-789321</p>
</div>
</div>
</body>
</html>
